Latest News

Royalty Pharma FY 2025 Earnings Snapshot Royalty Pharma (RPRX) has reported another quarter of royalty driven earnings, with Q3 FY 2025 revenue of US$609.3 million and basic EPS of US$0.67, alongside trailing 12 month revenue of about US$2.3 billion and EPS of US$1.76. The company’s quarterly revenue has moved from US$537.3 million in Q2 FY 2024 to US$593.6 million in Q4 FY 2024 and then into the US$568.2 million to US$609.3 million range across the first three quarters of FY 2025. Over the...

Dai-Dan Co., Ltd. reported past earnings for the nine months ended December 31, 2025, with sales of ¥180,189 million versus ¥185,850 million a year earlier, while net income increased to ¥19,176 million from ¥12,088 million and basic earnings per share rose to ¥148.6 from ¥93.98. This combination of lower sales but higher profits and earnings per share points to improved cost control or a more profitable project mix. We will now examine how Dai-Dan’s stronger profitability despite softer...

Why Nexra’s Taiwan O&M contract matters for Cadeler (OB:CADLR) Nexra’s new Operations & Maintenance contract in Taiwan, valued at more than €20 million and spanning two offshore wind farms from March 2026, gives investors another concrete data point on Cadeler’s aftermarket service ambitions. See our latest analysis for Cadeler. Cadeler’s Nexra contract lands at a time when momentum in the shares has been strong, with a 19.67% 1 month share price return and a 33.90% 3 month share price...

NetApp, Inc. recently presented at the WEST Conference 2026 at the San Diego Convention Center, highlighting its enterprise data infrastructure capabilities. The company’s growing success in winning new contracts, supported by billings growth and stronger efficiency-driven profits, underlines its operational momentum and cash generation strength. We’ll now explore how NetApp’s contract wins and efficiency gains might influence its investment narrative and future business positioning. The...

Kojamo Oyj (HLSE:KOJAMO) has wrapped up FY 2025 with fourth quarter revenue of €111.8 million, basic EPS of €0.06 and FFO per share of €0.14, shaping how investors may interpret a year marked by mixed earnings and a reported one off loss. The company has seen quarterly revenue move from €113.6 million in Q4 2024 to €113.6 million, €115.6 million and €114.3 million across the first three quarters of 2025. Over the same period, basic EPS has ranged from a loss of €0.04 per share in Q1 2025 to...

Heineken Holding FY 2025 results at a glance Heineken Holding (ENXTAM:HEIO) opened FY 2025 with first half revenue of €14.2b and Basic EPS of €1.35, setting a clear marker for how earnings are tracking against its recent turnaround in profitability. The company reported revenue of €14.8b in the first half of 2024 and €15.0b in the second half of 2024, followed by €14.2b in the latest half, while Basic EPS moved from a loss of €0.17 in early 2024 to €1.93 in late 2024 and €1.35 in the first...

Sparebanken Øst (OB:SPOG) has just posted its FY 2025 numbers, with fourth quarter revenue of NOK 222.9m and net income of NOK 407.3m setting the tone for the year. Over recent periods the bank has seen revenue move from NOK 238.7m in Q4 2024 to NOK 222.9m in Q4 2025, while trailing 12 month revenue has held around the NOK 1.0b mark, and EPS on a trailing 12 month basis has been in the NOK 6.2 to NOK 7.3 range. For investors, the mix of steady top line, solid net income and high net margin...

SRV Yhtiöt Oyj (HLSE:SRV1V) has just reported its FY 2025 numbers with Q4 revenue of €238.7 million, EPS of €0.62 and net income of €17.7 million, while trailing twelve month EPS came in at €0.78 on revenue of €728.6 million and net income of €15.5 million. The company has seen quarterly revenue range from €159.7 million to €238.7 million across 2025, with EPS moving from small losses in the first three quarters of the year to a clearly positive print in Q4. This sets up a picture where...

What Alnylam’s latest earnings tell you Alnylam Pharmaceuticals (ALNY) just reported Q4 and full year 2025 results that moved from losses to profits, with revenue and earnings shifting sharply higher compared with the previous year. For Q4 2025, revenue came in at US$1,097.03 million versus US$593.17 million a year earlier, and net income was US$111.54 million after a net loss of US$83.76 million in the prior year period. On a per share basis for the quarter, basic earnings from continuing...

Equity LifeStyle Properties (ELS) has declared a first quarter 2026 dividend of $0.5425 per common share, equivalent to $2.17 on an annualized basis, with payment scheduled for April 10 to shareholders of record on March 27. See our latest analysis for Equity LifeStyle Properties. At a share price of US$65.95, Equity LifeStyle Properties has seen a 10.30% year to date share price return and a 21.11% total shareholder return over five years. The recent dividend update helps frame current...

Alkermes (NasdaqGS:ALKS) has received Irish High Court approval to acquire Avadel Pharmaceuticals. The company has closed on more than US$1.5b in new credit facilities, which appears linked to funding the transaction. These developments mark a significant step in reshaping Alkermes' portfolio and capital structure. Alkermes focuses on neuroscience and oncology medicines, so adding Avadel Pharmaceuticals could reshape the mix of assets and future product opportunities. For investors, the...

Acast (OM:ACAST) closed out FY 2025 with Q4 revenue of SEK 732.6 million and basic EPS of SEK 0.29, while the trailing 12 month figures show revenue of SEK 2.5 billion and a net loss of SEK 112.4 million, or basic EPS of SEK 0.62 in losses. Over recent quarters, revenue has moved from SEK 535.4 million and a basic EPS loss of SEK 0.51 in Q1 2025 to SEK 642.2 million with basic EPS of SEK 0.04 in Q3 2025, before landing at the latest Q4 outcome. This sets up a picture of scale building against...

Finnair Oyj (HLSE:FIA1S) has just wrapped up FY 2025 with Q4 revenue of €831.3 million and EPS of €0.13, alongside trailing twelve month revenue of €3.23 billion and EPS of €0.09 that frame the latest quarterly print in a fuller context. Over recent periods the company has seen revenue move from €782.8 million and EPS of €0.039 in Q4 2024 to €831.3 million and EPS of €0.13 in Q4 2025, while trailing twelve month net income reached €18.4 million, setting up a story where thin margins and a...

Goldman Sachs has initiated coverage of Energy Fuels (TSX:EFR) with a Buy rating. The bank highlighted Energy Fuels' ownership of what it describes as the highest grade uranium deposit in the U.S. This new coverage draws attention to the company’s uranium assets rather than focusing on price targets. Energy Fuels, trading at CA$30.55, has attracted fresh attention after a strong run, with the share price up 4.2% over the past week and 14.3% over the past month. Longer term, the stock has...

With its stock down 14% over the past three months, it is easy to disregard nib holdings (ASX:NHF). However, stock...

In recent commentary, Federal Signal Corp. (NYSE:FSS) was highlighted for delivering 12.3% annual revenue growth over the past five years and an expected 15.6% sales increase over the coming twelve months, reflecting expanding demand for its safety and environmental solutions. An interesting takeaway is how this acceleration in projected sales growth reinforces perceptions that Federal Signal is capturing more business from municipalities and industrial customers seeking upgraded...

Allied Properties Real Estate Investment Trust (TSX:AP.UN) has wrapped up FY 2025 with fourth quarter revenue of CA$148.8 million, a Funds From Operations loss of CA$206.5 million, and a net income loss of CA$1.0 billion. This caps a year in which trailing twelve month revenue came in at CA$592.4 million and net income losses reached CA$1.3 billion. Over recent quarters, the trust has seen revenue move from CA$155.8 million in Q4 2024 to a range of CA$145.0 million to CA$150.6 million through...

Commerzbank (XTRA:CBK) has drawn fresh attention after reporting a record operating result for 2025, committing about €2.7b to shareholders through a higher dividend and two share buybacks, alongside an upbeat 2026 outlook. See our latest analysis for Commerzbank. The record 2025 result, higher dividend and buyback plans arrive after a mixed year in the market, with a 30 day share price return of a 3.66% decline but a very large 5 year total shareholder return of more than 7x. This suggests...

BNP Paribas Asset Management has disclosed crossing the 3% legal threshold of direct voting rights in Umicore. The disclosure reflects an increased stake that now exceeds the mandatory reporting level for shareholder voting power. Umicore (ENXTBR:UMI) is trading at €18.8, with the share price up 81.3% over the past year, while longer term returns over 3 and 5 years show declines of 37.6% and 55.1% respectively. This mix of strong recent performance and weaker multi year returns gives a...

Axon Enterprise (AXON) is approaching its February 24, 2026 earnings release, with investors watching how a projected near 20% EPS decline compares with revenue growth that is expected to exceed 30%. See our latest analysis for Axon Enterprise. At a share price of $434.45, Axon Enterprise has seen a 31.23% 1 month share price decline and a 22.89% year to date pullback, while its 3 year total shareholder return of 118.33% and 5 year total shareholder return of 143.55% show that longer term...

If you have been wondering whether Morningstar's share price now lines up with its underlying worth, this article is designed to walk you through that question clearly and calmly. The stock last closed at US$155.35, with returns showing a 13.9% decline over 7 days, 28.9% decline over 30 days, 26.2% decline year to date, 51.1% decline over 1 year, 33.8% decline over 3 years and 36.3% decline over 5 years. These moves have arrived alongside ongoing investor interest in how Morningstar's...

If you are wondering whether Palomar Holdings at US$131.64 is offering fair value or a stretched price, you are in the right place. The stock has returned 7.0% over the last week, 0.9% over the past month, is roughly flat year to date at a 0.1% decline, and has returns of 20.8% over 1 year, 150.7% over 3 years and 28.6% over 5 years. Recent coverage has focused on how Palomar fits into the broader US insurance sector and how investors are treating companies that specialise in underwriting...

Harley-Davidson (HOG) is back in focus after its Q4 2025 update, where a larger than expected loss, weaker 2026 outlook and potential credit rating downgrade from S&P put fresh pressure on the stock. See our latest analysis for Harley-Davidson. The weak Q4 2025 earnings, cautious 2026 outlook and S&P credit watch have fed into a clear shift in sentiment, with Harley-Davidson’s 90 day share price return of 17.05% and 1 year total shareholder return of 18.93% both firmly negative and pointing...

How NoHo Partners Oyj Ended FY 2025 NoHo Partners Oyj (HLSE:NOHO) closed FY 2025 with fourth quarter revenue of €103.7 million and EPS of €0.27, alongside full year trailing twelve month EPS of €1.55 on revenue of €365.1 million. Over recent periods, the company has seen quarterly revenue move from €77.2 million in Q1 2025 to €87.6 million in Q2, €91.4 million in Q3 and €103.7 million in Q4, while EPS shifted from a small loss in Q1 to €0.085537 in Q2, €0.09 in Q3 and €0.27 in Q4. With a...